Genetic polymorphism of CYP2D6 in North Indian subjects

European Journal of Clinical Pharmacology

Volumn 54, Issue 9-10, 1998, Pages 787-791

  Lamba, V ^a   Lamba, J K ^a   Dilawari, J B ^a   Kohli, K K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CYP2D6; Phenotype; Polymorphism

Indexed keywords

CYTOCHROME P450; DEXTROMETHORPHAN;

ADULT; ARTICLE; DATA ANALYSIS; ETHNIC GROUP; FEMALE; FREQUENCY ANALYZER; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INDIAN; LIVER PARENCHYMA; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ADOLESCENT; ADULT; ANTITUSSIVE AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP2D6; DEXTROMETHORPHAN; FEMALE; GENE FREQUENCY; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0032429357     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050552     Document Type: Article

References (28)

1. Guengerich FP (1995) Human cytochrome P450 enzymes. In: de Montellano PRO (ed) Cytochrome P450 structure, mechanism and biochemistry. Plenum Press, New York, pp 473 535
2. Eichelbaum M, Gross AS (1990) The genetic polymorphism of debrisoquine/sparteine metabolism clinical aspects. Pharmacol Ther 46: 377-394
3. Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg MI, Sjoqvist F (1995) Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 274: 516-520
4. Agundez JAG, Martinez C, Ladero JM, Ledesma MC, Ramos JM, Martin R, Rodriguez A, Jara C, Benitez J (1994) Debrisoquin oxidation genotype and susceptibility to lung cancer. Clin Pharmacol Ther 55: 10-14
5. Kaisari A, Smith P, Jaczq E, McAllister B, Wilkinson GR, Ray WA, Branch RA (1987) Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res 47: 5488-5493
6. Baer AN, McAllister CB, Wilkinson GR, Woosley RL, Pincus T (1986) Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus. Arthr Rheum 29: 137-157
7. Agundez JAG, Jimenez-Jimenez FJ, Luengo A, Bernal ML, Molina JA, Ayuso L, Vasquez A, Parra J, Duarte J, Coria F, Ladero JM, Alvarez JC, Benitez J (1995) Association between the oxidative polymorphism and early onset of Parkinson's disease. Clin Pharmacol Ther 57: 291-298
8. Morgan MY, Reshef R, Shah RR, Oates NS, Smith RL, Sherlock S (1984) Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut 25: 1057-1064
9. Shah RR, Oates NS, Idle JR, Smith RL, Lockhart JDF (1982) Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J 284: 295-299
10. Oates NS, Shah RR, Idle JR, Smith RL (1981) Phenformin-induced lactic acidosis associated with impaired debrisoquine hydroxylation. Lancet 1: 837-838
11. Siddoway LA, Thompson KA, McAllister CB, Wang T, Wilkinson GR, Roden DM, Woosley RL (1987) Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 75: 785-791
12. Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJJ, Roden DM, Woosley RL (1990) The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone. N Engl J Med 322: 1764-1768
13. Funck-Brentano C, Turgeon J, Woosley RL, Roden DM (1989) Effect of low dose quinidine on encainide pharmacokinetics and pharmacodynamics: influence of genetic polymorphism. J Pharmacol Exp Ther 249: 134-142
14. Sindrup SH, Brosen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo HR, Gram LF (1991) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 48: 686-693
15. Alvan G, Bechtel P, Iselius L, Gundert-Remy U (1990) Hydroxylation polymorphism of debrisoquine and mephenytoin in European population. Eur J Clin Pharmacol 39: 533-537
16. Bertilsson L, Lou YQ, Du YL, Liu Y, Kuang TY, Liao YM (1992) Pronounced differences between native Chinese and Swedish population in the polymorphic hydroxylation of debrisoquine and S-mephenytoin. Clin Pharmacol Ther 31: 388-397
17. Evans DAP, Mahgoub A, Sloan TP, Idle JR, Smith RL (1980) A population and family study of the genetic polymorphism of the debrisoquine oxidation in British white population. J Med Genet 17: 102-105
18. Lamba JK, Dhiman RK, Kohli KK (1998) Genetic polymorphism of hepatic cytochrome P4502C19 in North Indian subjects. Clin Pharmacol Ther 63: 422-427
19. Singh KS, Bhalla V, Kaul V (1994) The biological variations in Indian populations. Anthropological survey of India. Oxford University Press, Delhi Bombay Calcutta Madras
20. Guttendorf RJ, Wedlund PJ, Blake J, Chang SL (1988) Simplified phenotyping with dextromethorphan by thin layer chromatography: application to clinical laboratory screening for deficiencies in oxidative drug metabolism. Ther Drug Monit 10: 490-498
21. Park YH, Kullberg MP, Hinsvark ON (1984) Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase-high performance liquid chromatography. J Pharm Sci 73: 24-29
22. Marshall PS, Straka RJ, Johnson K (1992) Determination of dextromethorphan and its O-demethylated metabolite from urine. Ther Drug Monit 14: 402-407
23. Endrenyi L, Mayank P (1991) A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot. Br J Clin Pharmacol 32: 159-166
24. Emery AEH, Mueller RF (1992) Elements of medical genetics. Churchill Livingstone, Edinburgh
25. Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7: 373-400
26. Jacqz E, Dulac H, Mathieu H (1988) Phenotyping polymorphic drug metabolism in the French Caucasian population. Eur J Clin Pharmacol 35: 167-171
27. Broly F, Gaedigk A, Heim M, Eichelbaum M, Morike K, Meyer UA (1991) Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population. DNA Cell Biol 10: 545-558
28. Daly AK, Steen VM, Fairbrother KS, Idle JR (1996) CYP2D6 multiallelism. In: Johnson EF, Waterman MR (eds) Methods in enzymology, vol 272, cytochrome P450: part B. Academic Press, New York, pp 199-210